COMPANY

Altay Therapeutics, Inc.

Keywords: small molecule oncology facioscapulohumeral muscular dystrophy cancer inflammatory diseases

Location: San Carlos, CA · source · Oct 2, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $15.74M (Form D filed Oct 2, 2026). SEC Form D 0002157551-26-000001 (Oct 2, 2026)
Evidence (1 event)
- Oct 2, 2026 · SEC Form D 0002157551-26-000001
  Name of Issuer: Altay Therapeutics, Inc.; CIK: 2157551; Address: San Carlos, CA; Submission type: D; Filing date: 2026-10-02; Industry Group: Biotechnology; Date of First Sale: 2026-09-17; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 45067885; Total Amount Sold: 15738155; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals